Reactogenicity, Safety, and Immunogenicity of a Live Monovalent H5N2 Influenza Vaccine

NCT01719783 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Influenza

Interventions

BIOLOGICAL: LAIV H5N2
OTHER: Placebo

Sponsor

PATH

Collaborators

[object Object]
[object Object]